Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

12.71
Delayed Data
As of Aug 26
 +0.17 / +1.36%
Today’s Change
6.17
Today|||52-Week Range
14.54
+2.58%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close12.54
Today’s open12.63
Day’s range12.14 - 13.27
Volume48,717
Average volume (3 months)98,669
Market cap$375.5M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+35.31%
Earnings growth (this year)+12.65%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.12

Competitors

 Today’s
change
Today’s
% change
MNKDMannKind Corp-0.05-5.61%
OMEDOncoMed Pharmaceutic...-0.10-0.96%
SRNESorrento Therapeutic...+0.06+0.91%
TRVNTrevena Inc+0.11+1.59%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$0.00
Annual profit (last year)-$82.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers

Search for Jobs